“Emerging Drug Targets and Novel Therapeutic Strategies in Triple-Negative Breast Cancer”, Int. J. Afr. Alliance Res. Advoc. Innov., vol. 2, no. 2, Apr. 2026, doi: 10.64261/r6npxx71.